US Stock MarketDetailed Quotes
KYTX Kyverna Therapeutics
- 15.500
- +0.870+5.95%
Close May 14 16:00 ET
- 15.800
- +0.300+1.94%
Post 17:40 ET
668.29MMarket Cap-11071P/E (TTM)
15.730High14.750Low337.70KVolume14.750Open14.630Pre Close5.20MTurnover2.03%Turnover RatioLossP/E (Static)43.12MShares35.06052wk High-5.09P/B258.46MFloat Cap12.26052wk Low--Dividend TTM16.68MShs Float35.060Historical High--Div YieldTTM6.70%Amplitude12.260Historical Low15.396Avg Price1Lot Size
About Kyverna Therapeutics Company
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Company Profile
SymbolKYTX
Company NameKyverna Therapeutics
Listing DateFeb 8, 2024
Issue Price22.00
CEODr. Peter Maag, PhD
MarketNASDAQ
Employees96
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5980 Horton Street,Suite 550
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-925-2492
Websitehttp://www.kyvernatx.com
Company Executives
- Name
- Position
- Salary
- Dr. Peter Maag, PhD
- Chief Executive Officer and Director
- 2.26M
- Ryan Jones
- Chief Financial Officer
- --
- Karen Walker
- Chief Technology Officer
- 1.08M
- James Chung, M.D.
- Chief Medical Officer
- 1.17M
- Ian T. Clark
- Chairman of the Board
- 306.74K
- Dominic Borie, M.D.
- President, Research and Development
- --
- Daniel K. Spiegelman
- Independent Director
- 245.05K
- Dr. Fred E. Cohen, D.Phil.,F.A.C.P.,M.D.
- Independent Director
- 155.05K
- Dr. Brian L. Kotzin, M.D.
- Independent Director
- 255.05K
- Dr. Beth C. Seidenberg,M.D.
- Independent Director
- 155.05K
- Dr. Steve Liapis, PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
